ERBB3 and ovarian carcinoma: For example, engagement of EGFR and HER3 signaling by HB-EGF and heregulin, respectively, activates YAP1 transcription regulator which in-turn, increases the expression of EGFR and HER3 as well as several of their ligands in ovarian cancer cells [172].